Apixaban
B0661025
Approved small_molecule completed
Quick answer
Apixaban for Atrial Fibrillation is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Atrial Fibrillation
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed